Evidence map›Paper›PMID 23071339›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Fatih M Uckun, Hong Ma, Jian Zhang, Zahide Ozer, Sinisa Dovat, Cheney Mao, Rita Ishkhanian, Patricia Goodman, Sanjive Qazi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article
  5. Multifaceted roles ofFrontiers in oncology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Ikaros family of zinc-finger proteins.Acta pharmaceutica Sinica. B · 2016
    Review
  18. Article
  19. Article
  20. Microfluidics: reframing biological enquiry.Nature reviews. Molecular cell biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Fatih M UckunDivision of Hematology-Oncology, Systems Immunobiology Laboratory, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Hong Ma
Jian Zhang
Zahide Ozer
Sinisa Dovat
Cheney Mao
Rita Ishkhanian
Patricia Goodman
Sanjive Qazi
Children's Center · USParker Hughes Cancer Center · USGustavus Adolphus College · USPenn State Milton S. Hershey Medical Center · USShanghai Jiao Tong University · CNUniversity of Minnesota · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 NanoparticlesU01CA151837 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2010 to 2014
$2.3M
The Role of Zinc Finger Genes in LeukemogenesisR01HL095120 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVAT, SINISA · 2009 to 2013
$1.8M
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALLR01CA154471 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2011 to 2015
$1.6M
Amplifying Radiation Potency Against Leukemic Stem CellsR21CA164098 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI UCKUN, FATIH M · 2012 to 2013
$377k
NCI NIH HHS P30 CA014089NCI NIH HHS P30CA014089NCI NIH HHS R01 CA154471NCI NIH HHS R01CA-154471NCI NIH HHS R21 CA164098NCI NIH HHS R21-CA-164098NCI NIH HHS U01 CA151837NCI NIH HHS U01-CA-151837NHLBI NIH HHS R01 HL095120
6 · The paper itself

Abstract

Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation of the earliest stages of lymphocyte ontogeny and differentiation. Functional deficiency of Ikaros has been implicated in the pathogenesis of acute lymphoblastic leukemia, the most common form of childhood cancer. Therefore, a stringent regulation of Ikaros activity is considered of paramount importance, but the operative molecular mechanisms responsible for its regulation remain largely unknown. Here we provide multifaceted genetic and biochemical evidence for a previously unknown function of spleen tyrosine kinase (SYK) as a partner and posttranslational regulator of Ikaros. We demonstrate that SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358 and S361, thereby augmenting its nuclear localization and sequence-specific DNA binding activity. Mechanistically, we establish that SYK-induced Ikaros activation is essential for its nuclear localization and optimal transcription factor function.

Indexed as

Cell NucleusHumansIkaros Transcription FactorIntracellular Signaling Peptides and ProteinsMutagenesis, Site-DirectedPhosphorylationPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein-Tyrosine KinasesSerineSyk KinaseIkaros Transcription FactorIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesSerineSyk KinaseSYK protein, human

Identifiers

PMID23071339
PMCPMC3497833
OpenAlexW2164265350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.